MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) Free cash flow 2016–2024
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$16.1MFY2024 · since FY2016: -$6.2M → -$16.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$16.1M | +0.4% |
| FY2023 | -$16.2M | +16.7% |
| FY2022 | -$19.4M | -27.5% |
| FY2021 | -$15.2M | +14.3% |
| FY2020 | -$17.8M | -21.5% |
| FY2019 | -$14.6M | -29.9% |
| FY2018 | -$11.3M | +1.7% |
| FY2017 | -$11.5M | -85.0% |
| FY2016 | -$6.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More MTNB financial trends
MTNB RevenueMTNB Net incomeMTNB Net marginMTNB Gross profitMTNB Gross marginMTNB Operating incomeMTNB Operating marginMTNB Operating cash flowMTNB Capital expendituresMTNB Return on equityMTNB Stock buybacksMTNB Dividends paidMTNB Total assetsMTNB Total liabilitiesMTNB Shareholders’ equityMTNB overview →